Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2013 Aug 1;1(4):e00568-13. doi: 10.1128/genomeA.00568-13

Complete Genome Sequence of Persistent Cystic Fibrosis Isolate Pseudomonas aeruginosa Strain RP73

Julie Jeukens a,, Brian Boyle a, Irene Bianconi b, Irena Kukavica-Ibrulj a, Burkhard Tümmler c, Alessandra Bragonzi b,, Roger C Levesque a
PMCID: PMC3731849  PMID: 23908295

Abstract

Pseudomonas aeruginosa can establish lifelong chronic airway infections in cystic fibrosis (CF) patients. However, the genetic features associated with long-term persistence in the lung are not understood. We sequenced the genome of P. aeruginosa strain RP73, which was isolated after 16.9 years of chronic lung infection in a CF patient.

GENOME ANNOUNCEMENT

The Gram-negative bacterium Pseudomonas aeruginosa is a clinically relevant opportunistic pathogen highly resistant to most classes of antibiotics (1). It is the leading cause of chronic long-term lung infections and death in cystic fibrosis (CF) individuals. Following an initial period of intermittent and acute infections, P. aeruginosa establishes a persistent lifestyle in CF airways (2). Long-term colonization of the host is maintained by patho-adaptive lineages, which are presumably clonal from the initially acquired strain (3). Adaptive and loss-of-function mutations are frequent in virulence genes, which are essential for the initiation of infection and transient-to-long-term persistence in CF airways (4, 5). We selected the multidrug resistant nonmucoid P. aeruginosa strain RP73 as a model to investigate the genomic basis for long-term persistence in CF lung infections. RP73 was isolated 16.9 years after the onset of infection in a CF patient from the Hannover cohort (6). RP73 can establish and maintain long-term lung infection in a murine model of chronic pneumonia (79) with histopathological lesions similar to those found in CF patients (10). Hence, this strain is particularly well suited for comparative genomics with other CF strains, the study of P. aeruginosa pathogenesis, and the evaluation of novel antimicrobial therapies.

Following isolation, strain RP73 was stored at –80°C in Tryptic soy broth (TSB) with 30% glycerol. Genomic DNA was isolated from an overnight culture using the DNeasy blood and tissue kit (Qiagen). Whole-genome shotgun DNA sequencing was performed using the Roche 454 pyrosequencing method on the Genome Sequencer FLX system with titanium chemistry at the Plateforme d’analyses génomiques of the Institut de Biologie Intégrative et des Systèmes (Université Laval). In total, 319,835,813 nucleotides were analyzed using the gsAssembler module of Newbler v2.5.3. A total of 68 contigs were produced; 40 were larger than 500 nucleotides. Genome finishing was performed using Consed v. 20 (11). Automated annotation was performed with xbase (12) and the NCBI Prokaryotic Genome Annotation Pipeline (PGAAP) using P. aeruginosa PAO1 as a reference genome.

The assembled RP73 genome consists of a single circular chromosome of 6,342,034 bp with an average G+C content of 66.5%, which is consistent with previously sequenced P. aeruginosa strains. It contains 6,052 putative genes (5,975 open reading frames [ORFs] and 77 RNA genes). Twelve genomic islands were predicted by IslandViewer analysis (13). Three of the genomic regions carrying putative islands distinguish RP73 from other P. aeruginosa reference genomes and correspond to regions of genome plasticity (14). Namely, the RP73 genome contains PAGI-9 (15) and plasmid pKLC102, which carries the pil gene cluster and chvB glucan synthetase (14). The RP73 genome also contains LESGI-4, which was identified in the Liverpool epidemic strain (16). More detailed analyses of the RP73 genome, including comparative analysis with other P. aeruginosa strains and identification of virulence factor-associated mutations, are in progress.

Nucleotide sequence accession number.

The complete RP73 genome sequence and annotation have been deposited at CCBJ/EMBL/GenBank under the accession number CP006245.1.

ACKNOWLEDGMENTS

R.C.L. is funded by Cystic Fibrosis Canada and by CIHR. J.J. holds a Cystic Fibrosis Canada postdoctoral research fellowship. This study was supported by a grant to A.B. from the Italian Cystic Fibrosis Foundation.

We thank members of the IBIS core facility for NGS sequencing and the IBIS bioinformatics group for genome assembly.

Footnotes

Citation Jeukens J, Boyle B, Bianconi I, Kukavica-Ibrulj I, Tümmler B, Bragonzi A, Levesque RC. 2013. Complete genome sequence of persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73. Genome Announc. 1(4):e00568-13. doi:10.1128/genomeA.00568-13.

REFERENCES

  • 1. Rehm BHA. 2008. Pseudomonas: model organism, pathogen, cell factory. Wiley-VCH Verlag GmbH & Co KGaA, Weinheim, Germany [Google Scholar]
  • 2. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317–325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183:444–452 [DOI] [PubMed] [Google Scholar]
  • 4. Nguyen D, Singh PK. 2006. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc. Natl. Acad. Sci. U. S. A. 103:8305–8306 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D’Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103:8487–8492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Bragonzi A, Wiehlmann L, Klockgether J, Cramer N, Worlitzsch D, Döring G, Tümmler B. 2006. Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 152:3261–3269 [DOI] [PubMed] [Google Scholar]
  • 7. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B. 2009. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 180:138–145 [DOI] [PubMed] [Google Scholar]
  • 8. Moalli F, Paroni M, Véliz Rodriguez T, Riva F, Polentarutti N, Bottazzi B, Valentino S, Mantero S, Nebuloni M, Mantovani A, Bragonzi A, Garlanda C. 2011. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J. Immunol. 186:5425–5434 [DOI] [PubMed] [Google Scholar]
  • 9. Paroni M, Moalli F, Nebuloni M, Pasqualini F, Bonfield T, Nonis A, Mantovani A, Garlanda C, Bragonzi A. 2013. Response of CFTR-deficient mice to long-term Pseudomonas aeruginosa chronic infection and PTX3 therapy. J. Infect. Dis. 208:130–138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Livraghi A, Randell SH. 2007. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol. Pathol. 35:116–129 [DOI] [PubMed] [Google Scholar]
  • 11. Gordon D, Abajian C, Green P. 1998. Consed: a graphical tool for sequence finishing. Genome Res. 8:195–202 [DOI] [PubMed] [Google Scholar]
  • 12. Chaudhuri RR, Loman NJ, Snyder LAS, Bailey CM, Stekel DJ, Pallen MJ. 2008. xBASE2: a comprehensive resource for comparative bacterial genomics. Nucleic Acids Res. 36:D543–D546. 10.1093/nar/gkm928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Langille MGI, Brinkman FSL. 2009. IslandViewer: an integrated interface for computational identification and visualization of genomic islands. Bioinformatics 25:664–665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Klockgether J, Cramer N, Wiehlmann L, Davenport CF, Tümmler B. 2011. Pseudomonas aeruginosa genomic structure and diversity. Front. Microbiol. 2:150. 10.3389/fmicb.2011.00150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Battle SE, Rello J, Hauser AR. 2009. Genomic islands of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 290:70–78 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, Bignell A, Clarke L, Seeger K, Saunders D, Harris D, Parkhill J, Hancock RE, Brinkman FS, Levesque RC. 2009. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res. 19:12–23 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES